- Home
- CCEL vs KZR Comparison
CCEL vs KZR Comparison
Compare CCEL & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- KZR
- Stock Information
- Founded
- CCEL 1989
- KZR 2015
- Country
- CCEL United States
- KZR United States
- Employees
- CCEL N/A
- KZR N/A
- Industry
- CCEL Managed Health Care
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- CCEL Health Care
- KZR Health Care
- Exchange
- CCEL Nasdaq
- KZR Nasdaq
- Market Cap
- CCEL 34.8M
- KZR 29.7M
- IPO Year
- CCEL 1997
- KZR 2018
- Fundamental
- Price
- CCEL $4.53
- KZR $3.92
- Analyst Decision
- CCEL Strong Buy
- KZR Hold
- Analyst Count
- CCEL 1
- KZR 2
- Target Price
- CCEL $8.50
- KZR $9.00
- AVG Volume (30 Days)
- CCEL 24.9K
- KZR 39.9K
- Earning Date
- CCEL 10-15-2025
- KZR 11-11-2025
- Dividend Yield
- CCEL 13.22%
- KZR N/A
- EPS Growth
- CCEL N/A
- KZR N/A
- EPS
- CCEL N/A
- KZR N/A
- Revenue
- CCEL $31,988,783.00
- KZR N/A
- Revenue This Year
- CCEL $1.75
- KZR N/A
- Revenue Next Year
- CCEL N/A
- KZR N/A
- P/E Ratio
- CCEL N/A
- KZR N/A
- Revenue Growth
- CCEL 1.10
- KZR N/A
- 52 Week Low
- CCEL $4.09
- KZR $3.56
- 52 Week High
- CCEL $9.43
- KZR $9.18
- Technical
- Relative Strength Index (RSI)
- CCEL 45.10
- KZR 52.09
- Support Level
- CCEL $4.51
- KZR $3.56
- Resistance Level
- CCEL $4.93
- KZR $3.96
- Average True Range (ATR)
- CCEL 0.14
- KZR 0.20
- MACD
- CCEL -0.02
- KZR 0.02
- Stochastic Oscillator
- CCEL 36.00
- KZR 66.67
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.